Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125982981 | 12598298 | 1 | I | 20160707 | 20160727 | 20160727 | EXP | US-JNJFOC-20160708185 | JANSSEN | 0.00 | A | M | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125982981 | 12598298 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | 125261 | SOLUTION FOR INJECTION | ||||||||
125982981 | 12598298 | 2 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125982981 | 12598298 | 3 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125982981 | 12598298 | 1 | Psoriasis |
125982981 | 12598298 | 2 | Headache |
125982981 | 12598298 | 3 | Back pain |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125982981 | 12598298 | Hepatic enzyme increased | |
125982981 | 12598298 | Inappropriate schedule of drug administration | |
125982981 | 12598298 | Psoriasis | |
125982981 | 12598298 | Synovial cyst | |
125982981 | 12598298 | Vessel puncture site pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |